Conclusions: UVVF z-scores is inversely correlated to UA PI, supporting that hypovolemic state is associated with low cardiac output and low end diastolic velocity. UVVF was not predictive of demise, although qualitative abnormalities such as absent or reversed end diastolic flow were. DV was not associated with UVVF changes, even in recipients. This could be further analysed by stages. Results: Fifty-five TTTS cases participated in this study. Twelve recipients (22%) showed abnormal DV flow. DV-PI showed a strong positive correlation with amniotic fluid NT-proBNP/TP level (r = 0.720, p < 0.001), and abnormal DV flow was related with significantly higher NT-proBNP/TP level than those without abnormal DV flow [5,305 (860-17,800) ng/g vs. 564 (101-9,050) ng/g, p < 0.001].
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Short-term and long-term neurodevelopmental outcome of monochorionic monoamniotic twin pregnancy Objectives: Monoamniotic twin is at particular risk for intrauterine fetal demise, primarily because of cord entanglement. Recently early inpatient management and elective delivery at 32-34 weeks of gestation results in survival rate between 70-90% of cases. However, the neurologic outcome of survived monoamniotic twin has not been well studied. We investigated short-term and long-term neurodevelopmental outcome in survived monoamniotic twin neonates. Methods: In this retrospective cohort, 304 monochorionic twin neonates (152 pairs) born in preterm (24-35+0 weeks of gestation) were found. After excluding cases with twin-specific complications (TTTS or TAPS) and cases with major anomaly or intrauterine fetal death, 138 neonates of monochorionic diamniotic (MCDA) twins and 38 neonates of monochorionic monoamniotic (MCMA) twins were included in the final analysis. Short-term outcome was defined as severe lesion in neonatal brain ultrasound and long-term outcome as presence of cerebral palsy, blindness, deafness, or developmental delay determined at 2 years old. The short-term and long-term neurodevelopmental outcome was compared between MCMA twin and MCDA twin. Results: MCMA twin had higher adverse outcomes than MCDA twin in terms of both short-term and long-term neurodevelopmental outcomes. This difference remained significant after adjustment for confounding variables including gestational age at delivery ( 
